Natural product-based therapy for acute respiratory distress syndrome: Chitosan inhibits acute lung injury via down regulation of its target gene, 19/April/2015, 18.17

Sunlight exposure stalls p53-mutated metastatic cancer progression: Calcitriol (1α, 25-dihydroxyvitamin D3) increases the expression of tumor suppressor p53 homolouge TAp63 and inhibits migration and invasion of metastatic cancer cells via down regulation of its target gene, 19/April/2015, 10.43 am
April 19, 2015
Natural product-based therapy for pulmonary arterial hypertension: Ursolic acid, enriched in apples, inhibits the development of pulmonary arterial hypertension via down regulation of its target gene Notch3, 19/April/2015, 18.21
April 19, 2015
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, Natural product-based therapy for acute respiratory distress syndrome: Chitosan inhibits acute lung injury via down regulation of its target gene, 19/April/2015, 18.17, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Significance: This study suggests, for the first time, that Chitosan, by suppressing the expression of its target gene, it may inhibit acute lung injury. Thereby, it may inhibit the progression of acute respiratory distress syndrome.  Thus, pharmacological formulations encompassing “Chitosan or small molecule compounds isolated from Chitosan extract  may be used to inhibit the progression of acute respiratory distress syndrome.

Amount: $ 300

Undisclosed information: How Chitosan inhibits the progression of acute respiratory distress syndrome

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Comments are closed.